Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Anabasis setifera leaf extract from arid habitat: A treasure trove of bioactive phytochemicals with potent antimicrobial, anticancer, and antioxidant properties

  • Amer M. Abdelaziz ,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    amermorsy@azhar.edu.eg (AMA); amr.hosny86@azhar.edu.eg (AHH)

    Affiliation Faculty of Science, Botany and Microbiology Department, Al-Azhar University, Cairo, Egypt

  • Mostafa A. Abdel-Maksoud,

    Roles Funding acquisition, Resources, Writing – review & editing

    Affiliation Botany and Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia

  • Sabiha Fatima,

    Roles Data curation, Formal analysis, Methodology, Software

    Affiliation Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia

  • Saeedah Almutairi,

    Roles Funding acquisition, Software, Writing – review & editing

    Affiliation Botany and Microbiology Department, College of Science, King Saud University, Riyadh, Saudi Arabia

  • Bushra Hafeez Kiani,

    Roles Formal analysis, Funding acquisition, Writing – review & editing

    Affiliation Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, Massachuesetts, United States of America

  • Amr H. Hashem

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    amermorsy@azhar.edu.eg (AMA); amr.hosny86@azhar.edu.eg (AHH)

    Affiliation Faculty of Science, Botany and Microbiology Department, Al-Azhar University, Cairo, Egypt

Abstract

The main objective of this study was to evaluate the biological activities of Anabasis setifera extract, including its antimicrobial, anticancer, and antioxidant properties. In the current study, Anabasis setifera leaves extract was evaluated for antimicrobial, anticancer, antioxidant activities and phytochemical analyses. Ethyl acetate extract of Anabasis setifera (EA-AS) exhibited promising antimicrobial activity toward Escherichia coli, Staphylococcus aureus, Salmonella typhimurium, Bacillus subtilis, Candida albicans, Aspergillus brasiliensis, Aspergillus fumigatus with MICs 62.5, 125, 62.5, 31.25, 62.5, 125 and 125 μg/mL respectively. Moreover, EA-AS showed anticancer activity at safe concentrations, where IC50 were 36.4 and 44 μg/mL toward Hep-G2 and MCF-7 cancerous cell lines. EA-AS was found to contain 55 significant compounds identified through gas chromatography mass spectrophotometry (GCMS). The most abundant compounds were 1,4-dimethoxy-6,7,8,9-tetrahydro-5-benzocycloheptenone (26.04%), hexa-2,4-diyn-1-ylbenzene (8.40%), dihydrobenzo[b]fluoranthene (6.10%), ethanone, 1-[2,3-dihydro-2-(1-methylethenyl)-5-benzofuranyl (6.10%), and valerenol (4.08%). GC mass analysis confirmed the antioxidant properties of AS by detecting several compounds with antioxidant activity, including hexa-2,4-diyn-1-ylbenzene, nerolidol, spathulenol, -naphthalenem ethanol, decahydro-4-trimethyl-8-methylene, hexadecenoic acid, tremetone, desmethoxyencecalin, heptadecyn-1-ol, thunbergol, hexadecanol, dotriacontane, taylorione, ligulatin, retinoic acid, and falcarinol. The analysis of EA-AS reveals that it is a rich source of valuable phytochemicals: total Phenolic Content: a promising 4,264 μg/mL /, suggesting substantial biological and pharmacological potential. Total tannin content: 391.17 μg/mL, indicating potential applications in industries like nutraceuticals, pharmaceuticals, and cosmetics. Total flavonoid content exceptionally high at 5,163 μg/mL, while the total alkaloid content measured 1,036.26 μg/mL. Additionally, EA-AS demonstrated antioxidant activity with an EC50 of 30.6 μg/mL. In conclusion, the comprehensive analysis of the EA-AS reveals its immense potential as a rich source of valuable phytochemicals with diverse bioactivities, warranting further in-depth studies to unlock its full pharmaceutical and commercial prospects. Our results suggest substantial biological and pharmacological prospects for EA-AS as a promising antimicrobial, anticancer, and potent antioxidant.

1. Introduction

Antimicrobial resistance (AMR) is a serious and increasing global health problem that occurs when microbes, including bacteria, viruses, and fungi, gain the capability to resist the effects of antimicrobial medications [1,2]. As a result, common treatments become ineffective, leading to prolonged illnesses, increased hospitalizations, and higher mortality rates [3]. AMR is particularly concerning in the context of cancer care, as cancer patients often have weakened immune systems that make them more susceptible to infections [1,4]. The rise of AMR is jeopardizing the progress made in cancer treatment, as oncologists are finding that their go-to antibiotics and antifungal medications are no longer effective against the infections that commonly afflict cancer patients [5]. Addressing AMR through improved antibiotic stewardship and the development of new antimicrobial agents is crucial for ensuring that cancer patients can receive the full course of their essential cancer treatments and have access to effective antimicrobial agents [6].

Cancer remains one of the leading causes of death worldwide, with many cancer types still lacking effective treatments. Traditional cancer drugs often have limited efficacy, with many patients either not responding or eventually developing resistance to the medications [7,8]. This can lead to disease progression and poor outcomes for patients. Additionally, these traditional therapies frequently come with significant side effects that can negatively impact a patient’s quality of life during treatment [8]. While progress has been made in developing more targeted and personalized cancer therapies, there remains an urgent need for continued research and development of new, more effective treatment strategies that can improve patient outcomes and quality of life [7,9]. This challenge highlights the importance of having alternatives to currently used materials that are more efficient and safer for humans and the environment. Therefore, a natural and safe source was considered for testing to address these challenges.

Anabasis setifera (AS) is a plant that belongs to the kingdom Plantae. It is classified within the phylum Tracheophyta, class Magnoliopsida, order Caryophyllales, Amaranthaceae family, under the subfamily Salsoloideae and the tribe Salsoleae. AS is a hardy, perennial plant that excels in extremely arid environments. This resilient species has developed unique adaptations to survive in areas characterized by high salinity and frequent droughts [10]. AS is a compact, woody subshrub that can grow up to 50 cm tall. It has a dense, branching stem covered in greyish-green, scale-like leaves that are succulent and help conserve water. The leaves are covered in trichomes, giving the plant a bristly appearance. The small, greenish-white flowers are arranged in terminal spikes or clusters and are not particularly noticeable. The plant produces small, one-seeded fruits called utricles that are designed for wind or animal dispersal. The genus Anabasis is known to be a rich source of biologically active secondary compounds (BASC), such as sesquiterpenes, diterpenes, triterpenes, saponins, phenolic acids, flavonoids, and betalain pigments. These diverse phytochemicals contribute to the wide range of pharmacological activities exhibited by Anabasis species [11]. The promising properties of AS suggest its potential as an effective, safe, and non-traditional treatment to limit the spread of pathogens resistant to conventional treatments. AS is found in various habitats in Egypt, including all Egyptian deserts and coastal areas due to the unique characteristics of AS highlight the plant’s adaptability to various environments and its ability to thrive in diverse ecological conditions [12]. The current study aimed to comprehensively evaluate the biological activities of the ethyl acetate extract derived from the leaves of the plant Anabasis setifera (EA-AS). This assessment will be coupled with a detailed phytochemical analysis of the extract to identify the key bioactive compounds responsible for these activities. The results of this investigation contribute to the growing body of knowledge on the therapeutic potential of AS and its possible applications in various industries, including medicine, pharmaceuticals, and cosmetics.

2. Materials and methods

Plant material

AS leaf samples were collected from Ain-Sokhna-Alqattamiya road, Suez, Egypt. The plant was identified by Prof. Dr. Abdou Marie Hamed from the Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt. The plant was kept in Faculty of Science herbarium, Al-Azhar University (Voucher no. 775). The experimental research and field studies, including the collection of plant material, were conducted in compliance with the relevant institutional, national, and international guidelines and legislation.

Extraction of bioactive metabolites

To prepare the AS extracts, 10 grams of powdered leaf materials were extracted using 100 ml of ethyl acetate. The solvent layer was separated using a separating funnel and then evaporated. AS extract was used as a stock for subsequent experiments.

Antimicrobial activity

The preliminary qualitative antibacterial effect of EA-AS extract was assessed following the agar well diffusion assay. The activity was evaluated against Gram-positive B. subtilis ATCC 6051 and S. aureus ATCC 25923 and Gram-negative S. typhimurium ATCC 14028 and E. coli ATCC 25922. All steps were performed under aseptic condition according to the Clinical Laboratory Standard Institute (CLSI) guiding principle [13]. Briefly, each tested bacterial strain, equivalent to 0.5 McFarland standard concentrations, was inoculated with sterile cotton swab on the surface of Mueller-Hinton agar (MHA) palate. Using sterile cork-borer, wells of 8 mm was made on the agar surface and 100 μL of the tested EA-AS extract (1000 μg/ml)/ethyl acetate (EA)/ SAM (1000 μg/ml)/ Fluconazole (1000 μg/ml) was separately placed into the obtained wells. After incubation at 37°C for 24 h for bacteria and 30°C for 48 and 96 h for fungi, each inhibition zone diameter was measured.

Additionally, the quantitative antibacterial activity of the EA-AS extract towards the tested stains was determined via broth microdilution assay. In brief, the crude extract was suspended in DMSO and tryptic soy broth (TSB) for preparation of stock concentration (1000 μg/ml) and two-fold serial dilution was created in 96-well microtiter plates. Each bacterium inoculum (10 μl) equivalent to 0.5 McFarland standard was then inoculated. Positive control containing the tested bacterial isolate in TSB and DMSO without the crude extract was included while, the applied negative control was consisted of TSB, DMSO, and crude extract without bacterial inoculum. After incubation at 37°C for 24 h, the lowest EA-AS concentration associated with no bacterial growth was recorded as the minimum inhibitory concentration (MIC).

Cytotoxicity and anticancer activity

The cytotoxicity assay was conducted following the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyletetrazolium bromide (MTT) protocol described by Van de Loosdrecht et al. [14]. The breast cancerous cell line (MCF-7), hepatocellular carcinoma cell line (Hep-G2) and normal human diploid (WI-38) cell lines, obtained from the American Type Culture Collection (ATCC), was used for assessment of EA extract of AS cytotoxic or anticancer effects, respectively. Also, Taxol as positive control was assessed as anticancer agent toward both MCF-7 and HeG2 cancerous cell line. The 96-well tissue culture plate was inoculated with 1 x 105 cells/ml (100 μl/well) and incubated at 37°C for 24 hours to develop a complete monolayer sheet. The growth medium was then decanted from the 96-well microtiter plates after a confluent sheet of cells was formed. The cell monolayer was washed twice with wash media. Two-fold dilutions of the tested sample were made in RPMI medium with 2% serum (maintenance medium). 0.1 mL of each dilution was tested in different wells, leaving 3 wells as controls, receiving only maintenance medium. The plate was incubated at 37°C and examined. Cells were checked for any physical signs of toxicity, e.g. partial or complete loss of the monolayer, rounding, shrinkage, or cell granulation. MTT solution was prepared (5mg/ml in PBS) (BIO BASIC CANADA INC). 20 μL of MTT solution were added to each well. The plate was placed on a shaking table, 150 rpm for 5 minutes, to thoroughly mix the MTT into the media. The plate was then incubated (37°C, 5% CO2) for 4 h to allow the MTT to be metabolized. The media was dumped off and the plate was dried on paper towels to remove residue if necessary. The formazan (MTT metabolic product) was resuspended in 200 uL DMSO. The plate was placed on a shaking table, 150 rpm for 5 min, to thoroughly mix the formazan into the solvent. The optical density was read at 560 nm and the background was subtracted at 620nm. The optical density should be directly correlated with cell quantity. The cell viability and inhibition percentages were calculated according to Eqs (1) and (2): (1) (2)

Antioxidant activity

EA-AS was tested for its antioxidant activity following the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. The ability of the crude extract, at a concentration of 1000, 500, 250, 125, 62.5, 31.25, 15.62, 7.81 and 3.9 μg/mL to scavenge the DPPH radicals was examined. DPPH scavenging activity of different concentrations of EA extract of AS was determined via calculation of the percentage of antioxidant activity, in correlation to ascorbic acid (AA), following Eq (3): (3)

Total phenolics content (TPC)

TPC was measured using the Folin-Ciocalteu (FC) method, as described by [15]. Specifically: 50 μL of EA-AS was pipetted into test tubes and adjusted to 1 mL by D water. 0.5 mL of 1 N FC reagent was added to each tube, including the blank, and allowed to stand for 5 minutes at 25°C. Then, 2.5 mL of 5% Na2CO3 sol was added. After 25°C for 40 minutes absorbance was measured at 725 nm. Total phenolic content was expressed as micrograms of gallic acid equivalent.

Total flavonoid content (TFC)

TFC of EA-AS was determined using the aluminum chloride (AlCl3) colorimetric method: 0.5 mL of the Launaea nudicaulis extract was pipetted into a series of test tubes. The volume in each tube was adjusted to 1 mL with DH2O. 150 μL of 5% NaNO2 solution was added to all the tubes and allowed to incubate for 5 minutes at 25°C. Then, 150 μL of 10% AlCl3 solution was added to all the test tubes and incubated for 6 minutes at 25°C. After this, 2 mL of 4% NaOH solution was added to all the tubes, and the final volume was made up to 5 mL with DH2O. The test tubes were vortexed and allowed to stand for 15 minutes and absorbance was measured at 510 nm [16]. The flavonoids content of extracts was estimated by using the quercetin standard calibration curve.

Tannin content (TC)

TC of the EA-AS was determined using the FD method, as described by Makkar [15]. Additionally, the non-tannin phenolics (NTP) were isolated and quantified: To isolate NTP, 0.5 mL of the plant extract and 0.5 mL of DH2O were mixed with 0.1 g of PVPP in a test tube. The mixture was incubated at 4°C for 4 hours and then centrifuged for 10 minutes. The supernatant, containing the NTP, was collected. For tannin determination, 0.5 mL of the FD reagent (1 N) and 100 μL of the NTP extract were combined, and the volume was adjusted to 1 mL with DH2O for each sample, including the blank. The samples were allowed to stand at 25°C for 5 minutes. Then, 2.5 mL of 5% Na2CO3 solution and incubated at 25°C for 40 minutes in the dark and measured at 725 nm. The tannin contents were determined by using Tannic as a reference compound.

Total alkaloids content (TAC)

TAC of the EA-AS was measured quantitatively using the method described by Harborne [17]. A 1 g sample of the AS powder was mixed with a 4:1 ratio of 70% ethanol and glacial acetic acid. The mixture was left to stand for at least 6 hours and then filtered. TAC in the supernatant were precipitated by the drop wise addition of concentrated ammonia solution. TAC were then filtered and dried in an oven at 70°C until they reached a constant weight. The alkaloid content was calculated and expressed as milligrams per 100 grams of dry weight of the AS plant sample. Atropine standard solution were used in determined the alkaloids.

GC mass analysis

The extracted compounds from AS were first dissolved in methanol (CH3OH). Then, the solution was dried using anhydrous sodium sulfate (Na2SO4) to remove any remaining water. Finally, the sample was passed through a 0.45 μm syringe filter before being injected into the GC-MS system. The GC-MS instrument used was a Trace GC Ultra-ISQ system from Thermo Scientific, USA. The initial column temperature was set at 70°C, then increased to 280°C at a rate of 5°C per minute and held for 2 minutes. This was followed by a further increase to 300°C at a rate of 10°C per minute. The extracted components were identified and quantified by comparing their mass spectra and retention times to the databases of known compounds from the Wiley 09 and NIST 11 libraries [18].

Statistical analysis

The experiment was conducted in triplicate, with the reported values representing the averages of three independent trials. The data was analyzed using a one-way analysis of variance (ANOVA) model to determine if there were significant differences between the groups (p<0.05).

3. Results and discussion

Antimicrobial activity

According to recent studies, plant leaf extracts have shown promising antimicrobial activity [19,20]. Researchers have identified various phytochemicals, such as phenolic compounds, flavonoids, and terpenoids, within these extracts that exhibit inhibitory effects against a wide range of microorganisms, including bacteria, fungi, and viruses [21,22]. These natural antimicrobials offer a sustainable alternative to synthetic antibiotics, and their potential applications range from food preservation to the development of novel therapeutic agents. In the current study, ethyl acetate extract of Anabasis setifera leaves (EA-AS) was evaluated for antimicrobial activity as illustrated in Fig 1 and S1 Table in S1 File.

thumbnail
Fig 1. Minimum inhibitory concentrations of EA-AS and SAM/Fluc toward selected bacterial and fungal strains.

* EA-AS = Ethyl acetate extract of Anabasis setifera leaves, Fluc = Fluconazole, SAM = Ampicillin/sulbactam, and MIC = minimum inhibitory concentration. E. coli = Escherichia coli, S. aureus = Staphylococcus aureus, S. typhimurium = Salmonella typhimurium, B. subtilis = Bacillus subtilis. C. albicans = Candida albicans, A brasiliensis = Aspergillus brasiliensis, A. fumigatus = Aspergillus fumigatus. Standards were used Ampicillin/sulbactam in bacteria (E. coli, S. aureus, S. typhimurium and B. subtilis) and Fluconazole in fungi (Candida albicans, Aspergillus brasiliensis, Aspergillus fumigatus).

https://doi.org/10.1371/journal.pone.0310298.g001

EA-AS exhibited outstanding antimicrobial activity toward E. coli, S. aureus, S. typhimurium and B. subtilis with inhibition zones 26.6±1.53, 25.2±1.21, 28.9±1.35 and 30.0±1.0 respectively (Table 1). Furthermore, minimum inhibitory concentrations of EA-AS against all tested bacteria were determined (Fig 1). Results illustrated that, MICs of EA-AS toward E. coli, S. aureus, S. typhimurium and B. subtilis were 62.5, 125, 62.5 and 31.25 μg/mL respectively. Ampicillin/sulbactam as a standard antibiotic showed antibacterial activity where inhibition zones were 19.16 ± 1.26, 16.0 ± 1.0, 24.83 ± 1.25 and 21.16 ± 0.76 mm toward E.coli, S. aureus, S. typhimurium and B. subtilis. Also, MICs of SAM were 250, 250, 125 and 125 μg/ml respectively. Additionally, EA-AS showed antifungal activity against C. albicans, A. brasiliensis and A. fumigatus with inhibition zones 24.33 ± 0.57, 15.96 ± 0.95 and 14.66±0.57 mm. Moreover, MIC of EA-AS extract against C. albicans was 125 μg/ml, while as MIC of EA-AS toward A. brasiliensis and A. fumigatus was 250 for both. Moreover, Fluconazole exhibited antifungal activity against C. albicans, A. brasiliensis and A.fumigatus with inhibition zones 22.27 ± 1.41, 12.0±0.9 and 16.17 ± 1.76 mm. Furthermore, MICs of Fluconazole toward C. albicans, A. brasiliensis and A.fumigatus 250, 500 and 250 μg/ml respectively.

The genus Anabasis, a group of halophytic (salt-tolerant) plants native to arid regions of Central Asia and the Middle East, has demonstrated promising AMA. Maatalah et al. [23] reported that, alkaloids and saponin extracts of Anabasis articulate showed AMA against E. coli ATCC 25922, S. aureus ATCC 6538, K. pneumonia, B. subtilis ATCC 6633, P. aeruginosa ATCC 14028, C. albicans with MIC from 0.5 to 1 mg/ml. Likewise, alkaloids which extracted from A. articulata stems exhibited AMA toward bacterial and unicellular fungal strains [24]. The AMA of plant leaves crude extracts can be attributed to several mechanisms of action, including membrane disruption, enzyme inhibition, inhibition of virulence factors, induction of oxidative stress, and disruption of biofilm formation [25,26]. The phytochemicals present in our extract, such as phenols, flavonois, tannins and alkaloids, can interact with and disrupt the integrity of the microbial cell membrane, leading to the leakage of cellular contents. These bioactive compounds can also interfere with the activity of essential enzymes involved in microbial metabolism, inhibit the production or activity of virulence factors, generate reactive oxygen species, and disrupt the formation of microbial biofilms [27,28].

Cytotoxicity and anticancer activity

Assessing the biosafety of plant extracts using cytotoxicity toward normal cell lines is a crucial step in evaluating their safety profile through determination safe concentrations which can be used in anticancer activity [29]. This information can then be used to establish a safety margin and guide further development and testing of the extract. In the current study, Wi 38 normal cell line was selected to determine the safety of the extract. Results illustrated that, IC50 of EA-AS toward Wi 38 normal cell line was 167 μg/mLas shown in Fig 2. In general, if the IC50 is ≥ 90 μg/mL, the material is classified as non-cytotoxic [30]. Therefore, EA-AS is considered safe to use. Thus, safe concentrations and maximum non-toxic concentrations of this extract were checked for anticancer activity.

thumbnail
Fig 2. In vitro cytotoxic activities of EA-AS extract against MCF-7 and HepG2 cell lines.

Data are represented as mean ± SD of three independent experiments. * EA-AS = Ethyl acetate extract of Anabasis setifera leaves, The breast cancerous cell line (MCF-7), hepatocellular carcinoma cell line (Hep-G2) and normal human diploid (WI-38) cell lines.

https://doi.org/10.1371/journal.pone.0310298.g002

Investigating the anticancer activity of plant extracts is an area of active research and great interest in the field of natural product drug discovery. In general, plant-derived compounds have shown promising potential as anticancer agents due to their diverse phytochemical profiles, which often include bioactive secondary metabolites with cytotoxic, anti-proliferative, and pro-apoptotic properties. In this study, EA-AS was evaluated for anticancer activity against Hep-G2 and MCF-7 cancerous cell lines (Fig 2). Results revealed that, EA-AS has promising anticancer activity toward Hep-G2 and MCF-7 where IC50 was 36.4 and 44 μg/ml respectively. In compared to Taxol, IC50 of taxol was 12.4 and 8.6 μg/mL respectively. Several studies have reported that extracts from various Anabasis species exhibited cytotoxicity against a range of cancer cell lines, including those derived from breast, lung, prostate, and leukemia [3133].

The anticancer mechanisms of plant extracts can be multifaceted, involving the modulation of key signaling pathways, the induction of cell cycle arrest, the triggering of programmed cell death (apoptosis), the inhibition of angiogenesis, and the suppression of metastasis [34]. Moreover, synergistic interactions between the diverse phytochemicals present in plant extracts can lead to enhanced anticancer activity compared to individual compounds [35]. The anticancer properties of EA-AS have been linked to several distinct mechanisms of action. Previous studies have demonstrated that Anabasis extracts, which are rich in BAC like alkaloids, flavonoids, and terpenoids, can induce apoptosis (programmed cell death) in a variety of cancer cell lines [31,33]. These EA-AS have been observed to activate caspase enzymes, key regulators of the apoptotic pathway, leading to the fragmentation of DNA and ultimately the death of cancer cells [36]. Additionally, plant extracts have demonstrated the ability to inhibit cell proliferation by disrupting the cell cycle and arresting cancer cells in specific phases, thereby preventing their uncontrolled division [37]. Furthermore, the extracts have been found to modulate cellular signaling pathways involved in cancer progression, such as the PI3K/Akt and MAPK pathways, effectively suppressing tumor growth and metastasis in in vivo animal models [34,38]. These multifaceted anticancer mechanisms highlight the therapeutic potential of Anabasis plant-derived compounds and warrant further investigation for the development of novel cancer treatments.

Antioxidant activity

The assessment of antioxidant activity is a critical component in the comprehensive evaluation of plant extracts and their potential therapeutic applications [39]. Many plant-derived compounds, such as polyphenols, carotenoids, and terpenoids, possess potent free radical-scavenging and reactive oxygen species (ROS)-neutralizing capabilities, which can have significant implications for their use in the prevention and management of various diseases [40,41]. In this study, EA-AS was assessed for antioxidant activity as shown in Table 2 and S2 Fig in S1 File. Results revealed that EA extract of AS showed antioxidant activity where EC50 (concentration required to obtain a 50% antioxidant effect) was 30.6 μg/mL. In compared to positive control (ascorbic acid), EA-AS had antioxidant activity less than AA were EC50 of AA was 5.1 μg/mL. Senhaji et al. [42] reported that, Anabasis aretioïdes extract has antioxidant activity with EC50 = 52.91 μg/ml. Also, Anabasis articulata (Forssk.) Moq crude extract exhibited antioxidant activity with EC50 with 90 μg/mL[43]. Abdulsahib et al. [44] evaluated Anabasis articulata Stem Extract for antioxidant activity, where results showed potent activity with EC50 94.7 μg/mL. Furthermore, leaves of Anabasis Articulata from Algerian habitat showed antioxidant activity using DPPH with EC50 ranged from 3.200 ± 0.088 to 4.900 ± 0.130 μg/mL [45]. The antioxidant activity of the extract is associated with the presence of compounds with high antioxidant activity, as proven by GC mass analysis. The GC mass analysis of the extract confirmed the presence of the following compounds: hexa-2,4-diyn-1-ylbenzene, nerolidol, Spathulenol, 2-naphthalenemethanol, decahydro-4-trimethyl-8-methylene, hexadecenoic acid, tremetone, desmethoxyencecalin, 13-heptadecyn-1-ol, dotriacontane, taylorione, retinoic acid, benz[e]acephenanthrylen-3a-(1h)-ol, 2,3-dihydro, methyl commate d, and pectolinaringenin.

thumbnail
Table 2. Antioxidant activity of EA-AS using DPPH method.

https://doi.org/10.1371/journal.pone.0310298.t002

Phytochemical analysis

The result of the total phenolic content of AS being 4,264 μg /ml is a promising result and suggests that the plant may have significant biological and pharmacological potential (Fig 3) and S2 Table in S1 File. The AS may have significant antioxidant, anti-inflammatory, and AMA. The results of this study corroborate the findings reported by Gheraissa et al. [46] which indicated that AS exhibits antibacterial activity specifically against S. aureus, L. innocua, and E. coli. Tannins are a class of polyphenolic compounds that have been linked to several beneficial activities, including antioxidant, anti-carcinogenic, and AMA [47]. The total tannin content of the AS extract was found to be 391.17μg/ml. The presence of tannins in the AS extract suggests that it may have potential applications in various industries, including nutraceuticals, pharmaceuticals, and cosmetics. Flavonoids are a diverse group of plant-derived compounds that are renowned for their antioxidant, anti-inflammatory, and neuroprotective properties [48]. The total flavonoid content of the AS sample was found to be exceptionally high, reaching 5,163 μg/mL (Fig 3). This remarkably elevated flavonoid concentration further reinforces the potential bioactive and therapeutic capabilities of this plant extract. The abundance of these beneficial flavonoids suggests that AS may possess a wide range of valuable medicinal applications. The total alkaloid content of the EA-AS was found to be 1036.26 μg/ml. Alkaloids are a class of nitrogen-containing organic compounds that are known for their pharmacological activities. Phenolics, tannins, flavonoids, and alkaloids have significant important for maintaining health and preventing disease as well as nutritional supplements. Thus, they play significant roles in traditional and modern medicine, showcasing their potential for various therapeutic applications, including antioxidant, anti-inflammatory, and antimicrobial properties.

thumbnail
Fig 3. Quantitative phytochemical analysis of Anabasis setifera.

https://doi.org/10.1371/journal.pone.0310298.g003

GC-MS

EA-AS plant was found to contain 55 significant compounds that were identified through GC mass analysis. The most major compounds were 1,4-dimethoxy-6,7,8 9-tetrahydro-5-benzocycloheptenone (26.04%), hexa-2,4-diyn-1-ylbenzene (8.40%), dihydrobe nzo [b] fluoranthene (6.10%), ethanone, 1-[2,3-dihydro-2-(1- methylethenyl)-5-benzofuranyl (6.10%), and valerenol (4.08%) (Table 3 in S1 File and Fig 4). 1,4-dimethoxy-6,7,8,9-tetrahydro-5-benzocycloheptenone is a derivative of benzocycloheptenone with two methoxy substituents. It has been found to possess multiple biological activities, including antioxidant, anti-inflammatory, hepatoprotective, neuroprotective, and antiviral properties (46). Hexa-2,4-diyn-1-ylbenzene is an aromatic organic compound identified in the extract of plants and it has been found to exhibit anticancer, antioxidant, and antifungal activities [47]. Ethanone, 1-[2,3-dihydro-2-(1-methylethenyl)-5-benzofuranyl], is a chemical compound with the molecular formula C14H14O. It is a derivative of benzofuran, a heterocyclic compound with a six-membered ring containing an oxygen atom. It serves as a precursor to various pharmaceuticals and has been used in the synthesis of several compounds with biological activities [48]. Valerenol is a bicyclic sesquiterpenoid alcohol found in plants, known for its anxiolytic (anti-anxiety) activity, making it a compound of interest for potential therapeutic applications in mental health and nervous system disorders [49].

thumbnail
Fig 4. Gas chromatography mass spectrophotometry (GCMS)of Ethyl acetate extract of Anabasis setifera leaves.

https://doi.org/10.1371/journal.pone.0310298.g004

The antioxidant properties of AS have been studied, and the GC mass analysis confirmed this by detecting many compounds with antioxidant activity, including hexa-2,4-diyn-1-ylbenzene, nerolidol, Spathulenol, -naphthalenem ethanol, decahydro-4-trimethyl-8-methylene, hexadecenoic acid, tremetone, desmethoxyencecalin, heptadecyn-1-ol, thunbergol, hexadecanol, dotriacontane, taylorione, ligulatin, retinoic acid, and falcarinol. Furthermore, the antioxidant properties of Anabasis setifera have been linked to a range of biological activities, including anti-inflammatory, AMA and anticancer effects. There were many compounds showed by GC mass have antimicrobial activity including, benzene, 1-(1,5-dimethyl-4-hexenyl)-4-methyl, acorenol, 2-fluorobenzoic acid. heptadecyl ester, cis-isoapiole, hexadecane, 2-naphthalenem ethanol, decahydro-4-trimethyl-8- methylene, hexadecenoic acid, 7-epi-cis-sesquisabin ene hydrate, 13-heptadecyn-1-ol, 1-hexadecanol, dotriacontane, taylorione, ligulatin, falcarinol, isochiapin B, terretonin, epipallensin, eowelline, ethanone, 1-[2,3-dihydro-2-(1- methylethenyl)-5-ben zofuranyl], Digoxigenin, tibolone, docosanol, artemisetin, benz[e]acephen anthrylen-3a- (1h)-ol, 2,3-dihydro, methyl-à-cyano-á-methoxy-p-nit rocinnamate, androst-2-en-4-one, 17-hydroxy, hahnfett, Phenanthrene, ctahydro-trim ethyl-7-(methylethyl), hexadecanoic acid, dotriacontane. There were many compounds showed by GC mass have anticancer activity including, hexa-2,4-diyn-1-ylbenzene, hexadecenoic acid, desmethoxyencecalin, 1-hexadecanol, gitoxigenin, furanether, falcarinol, digoxigenin, tibolone, docosanol, artemisetin, and sitosterol.

4. Conclusion

The comprehensive analysis of the Anabasis setifera leaf extract (EA-AS) reveals its immense potential as a rich source of valuable phytochemicals with diverse bioactivities. The extract exhibited potent AMA against a range of pathogenic microbes, suggesting its possible applications in AMA. Additionally, the extract demonstrated significant anticancer properties against liver and breast cancer cell lines, underscoring its potential as a natural anticancer agent. The GC-MS analysis of EA-AS identified a plethora of antioxidant compounds, corroborating the extract’s impressive antioxidant capacity. The exceptionally high contents of phenols, tannins, flavonoids, and alkaloids further highlight the phytochemical wealth of this plant, indicating its vast applications in the nutraceutical, pharmaceutical, and cosmetic industries. These findings collectively suggest that AS leaf extract is a treasure trove of bioactive phytochemicals with multifaceted therapeutic and industrial potential. Further in-depth studies on the mechanistic aspects and in vivo efficacy of this extract are warranted to unlock its full pharmaceutical and commercial prospects. The study requires further research to be beneficial, such as applying this extract in vivo, comparing it with currently used materials, and mixing them. Additionally, the extract should be applied on a more comprehensive scale.

Supporting information

S1 File. Supplementary file containing Table S1: Minimum inhibitory concentrations of EA-AS toward selected bacterial and fungal strains, Table S2: Phytochemical analysis, and Fig S1: Antioxidant activity of EA-AS using DPPH method.

https://doi.org/10.1371/journal.pone.0310298.s001

(DOCX)

Acknowledgments

The authors would like to express their thankful to the Botany and Microbiology Department, Faculty of Science, Al-Azhar University, for promoting this research.

References

  1. 1. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–18. pmid:26343252
  2. 2. Chinemerem Nwobodo D, Ugwu MC, Oliseloke Anie C, Al-Ouqaili MTS, Chinedu Ikem J, Victor Chigozie U, et al. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. 2022;36(9):e24655. pmid:35949048
  3. 3. Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. 2023;11(13). pmid:37444780
  4. 4. Shelke YP, Bankar NJ, Bandre GR, Hawale DV, Dawande P. An Overview of Preventive Strategies and the Role of Various Organizations in Combating Antimicrobial Resistance. Cureus. 2023;15(9):e44666. pmid:37799257
  5. 5. Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: Current perspectives. 2021;9:20503121211034366. pmid:34408877
  6. 6. Nolazco JI, Chang SL. The role of health-related quality of life in improving cancer outcomes. Journal of clinical and translational research. 2023;9(2):110–4. pmid:37179791
  7. 7. Shegebayev Z, Turgumbayeva A, Datkhayev U, Zhakipbekov K, Kalykova A, Kartbayeva E, et al. Pharmacological properties of four plant species of the genus Anabasis, Amaranthaceae. Molecules. 2023;28(11):4454. pmid:37298930
  8. 8. Kadrić L. The Presence of Bioactive Compounds in Plants of the Amaranthaceae Family and Their Use in Medicine: A Review. Journal of Natural Sciences and Engineering. 2022;4(1).
  9. 9. El-Keblawy A, Gairola S, Bhatt A. Maternal salinity environment affects salt tolerance during germination in Anabasis setifera: A facultative desert halophyte. Journal of Arid Land. 2016;8:254–63.
  10. 10. Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. Journal of clinical microbiology. 2020;58(3): pmid:31915289
  11. 11. Van de Loosdrecht A, Beelen R, Ossenkoppele g, Broekhoven M, Langenhuijsen M. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods. 1994;174(1–2):311–20. pmid:8083535
  12. 12. Makkar HP. Quantification of tannins in tree and shrub foliage: a laboratory manual: Springer Science & Business Media; 2003.
  13. 13. Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food chemistry. 1999;64(4):555–9.
  14. 14. Harborne A. Phytochemical methods a guide to modern techniques of plant analysis: springer science & business media; 1998.
  15. 15. Rivero-Cruz JF, Granados-Pineda J, Pedraza-Chaverri J, Pérez-Rojas JM, Kumar-Passari A, Diaz-Ruiz G, et al. Phytochemical constituents, antioxidant, cytotoxic, and antimicrobial activities of the ethanolic extract of Mexican brown propolis. Antioxidants. 2020;9(1):70. pmid:31940981
  16. 16. Fik-Jaskółka M, Mittova V, Motsonelidze C, Vakhania M, Vicidomini C, Roviello GN. Antimicrobial Metabolites of Caucasian Medicinal Plants as Alternatives to Antibiotics. Antibiotics. 2024;13(6):487. pmid:38927153
  17. 17. Manso T, Lores M, de Miguel T. Antimicrobial Activity of Polyphenols and Natural Polyphenolic Extracts on Clinical Isolates. Antibiotics. 2022;11(1):46. pmid:35052923
  18. 18. Patra AK. An overview of antimicrobial properties of different classes of phytochemicals. Dietary phytochemicals and microbes. 2012:1–32.
  19. 19. Sher A. Antimicrobial activity of natural products from medicinal plants. Gomal Journal of medical sciences. 2009;7(1).
  20. 20. Maatalah MB, Bouzidi NK, Bellahouel S, Merah B, Fortas Z, Soulimani R, et al. Antimicrobial activity of the alkaloids and saponin extracts of Anabasis articulate. J Biotechnol Pharm Res. 2012;3(3):54–7.
  21. 21. Belyagoubi-Benhammou N, Belyagoubi L, Gismondi A, Di Marco G, Canini A, Atik Bekkara F. GC/MS analysis, and antioxidant and antimicrobial activities of alkaloids extracted by polar and apolar solvents from the stems of Anabasis articulata. Medicinal Chemistry Research. 2019;28:754–67.
  22. 22. Górniak I, Bartoszewski R, Króliczewski J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochemistry reviews. 2019;18:241–72.
  23. 23. Simoes M, Bennett RN, Rosa EA. Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Natural product reports. 2009;26(6):746–57. pmid:19471683
  24. 24. Mickymaray S. Efficacy and mechanism of traditional medicinal plants and bioactive compounds against clinically important pathogens. Antibiotics. 2019;8(4):257. pmid:31835403
  25. 25. Mitropoulou G, Stavropoulou E, Vaou N, Tsakris Z, Voidarou C. Insights into Antimicrobial and Anti-Inflammatory Applications of Plant Bioactive Compounds. 2023;11(5). pmid:37317131
  26. 26. Khalil AMA, Abdelaziz AM, Khaleil MM, Hashem AH. Fungal endophytes from leaves of Avicennia marina growing in semi‐arid environment as a promising source for bioactive compounds. Letters in Applied Microbiology. 2021;72(3):263–74. pmid:33063859
  27. 27. Ioset J-R, Brun R, Wenzler T, Kaiser M, Yardley V. Drug screening for kinetoplastids diseases. A Training Manual for Screening in Neglected Diseases. 2009.
  28. 28. Mahalel UA, Abdel-Farid IB, Rowezak MM, El-Naggar SA, El-Said KS, Massoud D, et al. Phytochemical Screening and in vitro Anticancer Activity of Some Medicinal Plants Grown in the Kingdom of Saudi Arabia. International Journal of Morphology. 2024;42(2).
  29. 29. Shegebayev Z, Turgumbayeva A, Datkhayev U, Zhakipbekov K. Pharmacological Properties of Four Plant Species of the Genus Anabasis, Amaranthaceae. 2023;28(11). pmid:37298930
  30. 30. Monteleone V, Ben Menni D, Belyagoubi-Benhammou N, Di Marco G, Canini A, Gismondi A. Anabasis articulata (Forssk.) Moq. food aqueous extract triggers oxidative stress-induced senescence and reduces metastatic power in MDA-MB-231 cells. Journal of Functional Foods. 2024;116:106203.
  31. 31. Ismail NI, Othman I. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. 2019;20(10). pmid:31108984
  32. 32. Rudzińska A, Juchaniuk P, Oberda J, Wiśniewska J, Wojdan W, Szklener K. Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. 2023;15(8). pmid:37111115
  33. 33. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25(34):4798–811. pmid:16892092
  34. 34. Sohel M, Aktar S, Biswas P, Amin MA, Hossain MA, Ahmed N, et al. Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review. 2023;12(13):14556–83. pmid:37132286
  35. 35. Sun LR, Zhou W, Zhang HM, Guo QS, Yang W, Li BJ, et al. Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer. Frontiers in oncology. 2019;9:1153. pmid:31781485
  36. 36. Gheraissa N, Chemsa A, Cherrada N, Erol E, Elsharkawy E. Anabasis oropediorum Maire. as a health-promoting source: Phytochemical content, in vitro antioxidant, antidiabetic, antibacterial, and anti-inflammatory potential. Journal of Research in Pharmacy. 2023;27(5). http://dx.doi.org/10.29228/jrp.474.
  37. 37. Sehgal R, Sharma AK, Singh BJ, Saini RV, Saini AK, Beniwal V. Augmenting the antioxidant, anti-bacterial and anti-carcinogenic potential of Terminalia chebula and Terminalia bellirica after tannin acyl hydrolase mediated biotransformation. Biocatalysis and Agricultural Biotechnology. 2024;56:103045.
  38. 38. Kciuk M, Garg N, Dhankhar S, Saini M, Mujwar S, Devi S, et al. Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin. Pharmaceuticals. 2024;17(6):701. pmid:38931368
  39. 39. Krishnaiah D, Sarbatly R, Nithyanandam R. A review of the antioxidant potential of medicinal plant species. Food and Bioproducts Processing. 2011;89(3):217–33.
  40. 40. Salehi B, Azzini E, Zucca P, Maria Varoni E, Anil Kumar N V., Dini L, et al. Plant-derived bioactives and oxidative stress-related disorders: a key trend towards healthy aging and longevity promotion. Applied Sciences. 2020;10(3):947.
  41. 41. Akbari B, Baghaei‐Yazdi N, Bahmaie M, Mahdavi Abhari F. The role of plant‐derived natural antioxidants in reduction of oxidative stress. BioFactors. 2022;48(3):611–33. pmid:35229925
  42. 42. Senhaji S, Lamchouri F, Toufik H. Phytochemical content, antibacterial and antioxidant potential of endemic plant anabasis aretioïdes coss. & moq.(Chenopodiaceae). BioMed research international. 2020;2020(1):6152932. pmid:32076611
  43. 43. Al-Joufi FA, Jan M, Zahoor M, Nazir N, Naz S, Talha M, et al. Anabasis articulata (Forssk.) Moq: A Good Source of Phytochemicals with Antibacterial, Antioxidant, and Antidiabetic Potential. Molecules. 2022;27(11):3526. pmid:35684464
  44. 44. Abdulsahib K, Abdulkareem A, Ban Jumaa Q, Hayder S. Antiangiogenesis and antioxidant effect of Anabasis articulata stems extracts. Int J Pharm Sci Rev Res. 2016;41(2):88–94.
  45. 45. Kambouche N, Hamiani A, Zitouni H. Phenolics Compounds and Biological Activity of Leaves of Anabasis Articulata, an Algerian Medicinal Plant. International Journal of Pharmaceutical Research and Allied Sciences. 2019;8(4–2019):1–5.
  46. 46. Gao H, Huang Y-N, Gao B, Xu P-Y, Inagaki C, Kawabata J. α-Glucosidase inhibitory effect by the flower buds of Tussilago farfara L. Food chemistry. 2008;106(3):1195–201.
  47. 47. Youssef AM, Maaty DA, Al-Saraireh YM. Phytochemical analysis and profiling of antioxidants and anticancer compounds from Tephrosia purpurea (L.) subsp. apollinea family Fabaceae. Molecules. 2023;28(9):3939. pmid:37175349
  48. 48. Kutluk I, Aslan M, Orhan I, Özçelik B. Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species. South African Journal of Botany. 2018;119:252–7.
  49. 49. Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H. Extracts of Valeriana officinalis L. sl show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine. 2008;15(1–2):2–15. pmid:18160026
  50. 50. Goswami L, Gupta L, Paul S, Vijayaraghavan P, Bhattacharya AK. Design and Synthesis of 1, 3‐Diynes as Potent Antifungal Agents against Aspergillus fumigatus. ChemMedChem. 2023;18(9):e202300013. pmid:36852543
  51. 51. Aladejana EB, Adelabu OA, Aladejana AE, Ndlovu SI. Antimicrobial Properties of Alternative Medicines Used in the Management of Infections in Diabetic Patients: A Comprehensive Review. Pharmacological Research-Modern Chinese Medicine. 2024:100432.
  52. 52. Zellner BD, Amorim ACL, Miranda ALPd, Alves RJ, Barbosa JP, Costa GLd, et al. Screening of the odour-activity and bioactivity of the essential oils of leaves and flowers of Hyptis passerina Mart. from the Brazilian Cerrado. Journal of the Brazilian Chemical Society. 2009;20:322–32.
  53. 53. de Moura DF, Rocha TA, de Melo Barros D, da Silva MM, dos Santos Santana M, Neta BM, et al. Evaluation of the antioxidant, antibacterial, and antibiofilm activity of the sesquiterpene nerolidol. Archives of Microbiology. 2021;203(7):4303–11. pmid:34110480
  54. 54. Krist S, Banovac D, Tabanca N, Wedge DE, Gochev VK, Wanner J, et al. Antimicrobial activity of nerolidol and its derivatives against airborne microbes and further biological activities. Natural product communications. 2015;10(1):1934578X1501000133. pmid:25920237
  55. 55. Dos Santos E, Radai JAS, do Nascimento KF, Formagio ASN, de Matos Balsalobre N, Ziff EB, et al. Contribution of spathulenol to the anti-nociceptive effects of Psidium guineense. Nutritional Neuroscience. 2022;25(4):812–22. pmid:32912110
  56. 56. Api A, Belsito D, Botelho D, Bruze M, Burton G, Buschmann J, et al. RIFM fragrance ingredient safety assessment, citronellyl acetate, CAS Registry Number 150-84-5. Food Chem Toxicol. 2022;159:112710. pmid:34848257
  57. 57. Pisanenko D, Palii G, Kryuchkova V. Synthesis and antimicrobial activity of cyclopentyl-substituted halogenophenoxyacetic acids and their amides. Pharmaceutical chemistry journal. 2010;44:424–6.
  58. 58. Wangchuk P, Keller PA, Pyne SG, Taweechotipatr M, Kamchonwongpaisan S. GC/GC-MS analysis, isolation and identification of bioactive essential oil components from the Bhutanese medicinal plant, Pleurospermum amabile. Natural Product Communications. 2013;8(9):1934578X1300800930. pmid:24273872
  59. 59. Yogeswari S, Ramalakshmi S, Neelavathy R, Muthumary J. Identification and comparative studies of different volatile fractions from Monochaetia kansensis by GCMS. Global Journal of Pharmacology. 2012;6(2):65–71.
  60. 60. Tunca-Pinarli Y, Benek A, Turu D, Bozyel ME, Canli K, Altuner EM. Biological Activities and Biochemical Composition of Endemic Achillea fraasii. Microorganisms. 2023;11(4):978. pmid:37110401
  61. 61. Sharaf MH, Abdelaziz AM, Kalaba MH, Radwan AA, Hashem AH. Antimicrobial, antioxidant, cytotoxic activities and phytochemical analysis of fungal endophytes isolated from ocimum basilicum. Applied biochemistry and biotechnology. 2022:1–19. pmid:34661866
  62. 62. Benites J, Gutierrez E, López J, Rojas M, Rojo L, do Céu Costa M, et al. Evaluation of analgesic activities of tremetone derivatives isolated from the Chilean altiplano medicine Parastrephia lepidophylla. Natural Product Communications. 2012;7(5):1934578X1200700517. pmid:22799089
  63. 63. Oleszek M, Kowalska I, Oleszek W. Phytochemicals in bioenergy crops. Phytochemistry Reviews. 2019;18:893–927.
  64. 64. Petrović G, Stamenković J, Stojanović G, Zlatković B, Jovanović O. Essential oil analysis of different plant parts of Geocaryum cynapioides (Guss.) L. Engstrand. Biologica Nyssana. 2018;9(1):31–5.
  65. 65. Ashrafi B, Ramak P, Ezatpour B, Talei GR. Biological activity and chemical composition of the essential oil of Nepeta cataria L. J Res Pharm. 2019;23(2):336–43.
  66. 66. Mothana RA, Al-Rehaily AJ, Schultze W. Chemical analysis and biological activity of the essential oils of two endemic Soqotri Commiphora species. Molecules. 2010;15(2):689–98. pmid:20335939
  67. 67. Ganassi S, Grazioso P, De Cristofaro A, Fiorentini F, Sabatini MA, Evidente A, et al. Long chain alcohols produced by Trichoderma citrinoviride have phagodeterrent activity against the bird cherry-oat aphid Rhopalosiphum padi. Frontiers in microbiology. 2016;7:297. pmid:27014220
  68. 68. El-Fayoumy EA, Shanab SM, Gaballa HS, Tantawy MA, Shalaby EA. Evaluation of antioxidant and anticancer activity of crude extract and different fractions of Chlorella vulgaris axenic culture grown under various concentrations of copper ions. BMC Complementary Medicine and Therapies. 2021;21:1–16. pmid:33546663
  69. 69. Bedir E, Karakoyun Ç, Doğan G, Kuru G, Küçüksolak M, Yusufoğlu H. New cardenolides from biotransformation of gitoxigenin by the endophytic fungus Alternaria eureka 1E1BL1: characterization and cytotoxic activities. Molecules. 2021;26(10):3030. pmid:34069653
  70. 70. Soosairaj S, Dons T. Bio-active compounds analysis and characterization in ethanolic plant extracts of Justicia tranquebariensis L.(Acanthaceae)-using GC-MS. Int J Chemtech Res. 2016;9(7):260–5.
  71. 71. Signe JK, Aponglen GA, Ajeck JM, Taiwe GS. Anticonvulsant activities of friedelan-3-one and n-dotriacontane both isolated from Harungana madagascariensis Lam (Hypericaceae) seeds extracts. Journal of Medicinal Plants Research. 2020;14(10):509–17.
  72. 72. Durán-Peña MJ, Ares JMB, Hanson JR, Collado IG, Hernández-Galán R. Biological activity of natural sesquiterpenoids containing a gem-dimethylcyclopropane unit. Natural product reports. 2015;32(8):1236–48. pmid:25994531
  73. 73. Humber DC, Jones PS, Phillipps GH. Synthesis and biological activity of some cardiotonic compounds related to gitoxigenin. Steroids. 1985;45(1):19–30. pmid:4089910
  74. 74. Kitel R, Byczek-Wyrostek A, Hopko K, Kasprzycka A, Walczak K. Effect of Selected Silyl Groups on the Anticancer Activity of 3, 4-Dibromo-5-Hydroxy-Furan-2 (5 H)-One Derivatives. Pharmaceuticals. 2021;14(11):1079. pmid:34832861
  75. 75. Arnold A, Potts GO, Beyler AL. Relative oral anabolic to androgenic activity ratios of androisoxazole, ethylestrenol, methylandrostenolisoxazole and testosterone. European Journal of Endocrinology. 1963;44(4):490–8. pmid:14082537
  76. 76. Osmakov DI, Kalinovskii AP, Belozerova OA, Andreev YA, Kozlov SA. Lignans as pharmacological agents in disorders related to oxidative stress and inflammation: chemical synthesis approaches and biological activities. International journal of molecular sciences. 2022;23(11):6031. pmid:35682715
  77. 77. Khatkar S, Lather A, Khatkar A. Valerenic and acetoxyvalerenic acid. Naturally Occurring Chemicals Against Alzheimer’s Disease: Elsevier; 2021. p. 117–25.
  78. 78. Karkas MD, Porco JA Jr, Stephenson CR. Photochemical approaches to complex chemotypes: applications in natural product synthesis. Chemical Reviews. 2016;116(17):9683–747. pmid:27120289
  79. 79. Adaeva OI, Demchuk DV, Semenov VV. 6, 7-Dihydroxy-5, 8-dimethoxy-2 H-chromen-2-one. Molbank. 2023;2023(3):M1702
  80. 80. Kong R, Cui Y, Fisher GJ, Wang X, Chen Y, Schneider LM, et al. A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin. Journal of cosmetic dermatology. 2016;15(1):49–57. pmid:26578346
  81. 81. Zanotto-Filho A, Schröder R, Moreira JCF. Differential effects of retinol and retinoic acid on cell proliferation: a role for reactive species and redox-dependent mechanisms in retinol supplementation. Free radical research. 2008;42(9):778–88. pmid:18785048
  82. 82. Mohammed AE, Sonbol H, Alwakeel SS, Alotaibi MO, Alotaibi S, Alothman N, et al. Investigation of biological activity of soil fungal extracts and LC/MS-QTOF based metabolite profiling. Scientific reports. 2021;11(1):4760. pmid:33637771
  83. 83. Hashem AH, Al-Askar AA, Abd Elgawad H, Abdelaziz AM. Bacterial endophytes from Moringa oleifera leaves as a promising source for bioactive compounds. Separations. 2023;10(7):395.
  84. 84. Hamed A, Abdel-Razek AS, Omran DA, El-Metwally MM, El-Hosari DG, Frese M, et al. Terretonin O: A new meroterpenoid from Aspergillus terreus. Natural product research. 2020;34(7):965–74. pmid:30602325
  85. 85. Atkinson DJ, Brimble MA. Isolation, biological activity, biosynthesis and synthetic studies towards the rubromycin family of natural products. Natural product reports. 2015;32(6):811–40. pmid:25798711
  86. 86. Cahlíková L, Vrabec R, Pidaný F, Peřinová R, Maafi N, Mamun AA, et al. Recent progress on biological activity of Amaryllidaceae and further isoquinoline alkaloids in connection with Alzheimer’s disease. Molecules. 2021;26(17):5240. pmid:34500673
  87. 87. Tai B, Bai L, Ji R, Yu M, Huang L, Zheng H. Phytochemical and pharmacological progress on Syringa oblata, a traditional Mongolian medicine. Chinese Herbal Medicines. 2022;14(3):392–402. pmid:36118008
  88. 88. Attia MS, Sharaf MH, Hashem AH, Mahfouz AY, Daigham GE, Al-Askar AA, et al. Application of Rhizopus microsporus and Aspergillus oryzae to enhance the defense capacity of eggplant seedlings against Meloidogyne incognita. Notulae Botanicae Horti Agrobotanici Cluj-Napoca. 2023;51(3):1–23.
  89. 89. Ren Y-c, Bao Y-z, Liu J, Zhang X-k, Zhang Y-w, Sun X-L, et al. Synthesis of C3-Neoglycosides of digoxigenin and their anticancer activities. European Journal of Medicinal Chemistry. 2018;145:252–62. pmid:29329000
  90. 90. Notelovitz M. Postmenopausal tibolone therapy: biologic principles and applied clinical practice. Medscape General Medicine. 2007;9(1):2. pmid:17435612
  91. 91. Pope L, Marcelletti J, Katz L, Katz D. Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug. Journal of lipid research. 1996;37(10):2167–78. pmid:8906594
  92. 92. Li J, Zhou B. Biological actions of artemisinin: insights from medicinal chemistry studies. Molecules. 2010;15(3):1378–97. pmid:20335987
  93. 93. Thawabteh A, Juma S, Bader M, Karaman D, Scrano L, Bufo S, et al. The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens. Toxins, 11 (11): 656. 2019. pmid:31717922
  94. 94. Wood A, Levin W, Thakker D. Biological activity of benze (e) pyrene. An assessment based on mutagenic activities and metabolic profiles of the polycyclic hydrocarbon and its derivatives. J Biol Chem;(United States). 1979;254(11).
  95. 95. Jordan F. Investigation of Computer Vision and Deep Learning on Thoracic CT for Assessment and Evaluation of Coronary Artery Calcium, Emphysema, and COVID-19: The University of Chicago; 2022.
  96. 96. Suslov E, Ponomarev KY, Volcho K, Salakhutdinov N. Azaadamantanes, a New Promising Scaffold for Medical Chemistry. Russian Journal of Bioorganic Chemistry. 2021;47:1133–54. pmid:34931112
  97. 97. Sunol C, García DA, Bujons J, Krištofíková Z, Matyáš L, Babot Z, et al. Activity of B-nor analogues of neurosteroids on the GABAA receptor in primary neuronal cultures. Journal of medicinal chemistry. 2006;49(11):3225–34. pmid:16722640
  98. 98. Amiranashvili L, Nadaraia N, Merlani M, Kamoutsis C, Petrou A, Geronikaki A, et al. Antimicrobial activity of nitrogen-containing 5-α-androstane derivatives: in silico and experimental studies. Antibiotics. 2020;9(5):224. pmid:32365907
  99. 99. Das SK, Prusty A, Samantaray D, Hasan M, Jena S, Patra JK, et al. Effect of Xylocarpus granatum bark extract on amelioration of hyperglycaemia and oxidative stress associated complications in STZ‐induced diabetic mice. Evidence‐Based Complementary and Alternative Medicine. 2019;2019(1):8493190. pmid:31186667
  100. 100. Lotfy RA, El-Moaty A, Heba I. ANTI-BACTERIAL ACTIVITIES OF SOME ACTIVE CONSTITUENTS ISOLATED FROM PHLOMIS FLOCCOSA D. DON. Egyptian Journal of Desert Research. 2016;66(1):69–78.
  101. 101. Kovács A, Vasas A, Hohmann J. Natural phenanthrenes and their biological activity. Phytochemistry. 2008;69(5):1084–110. pmid:18243254
  102. 102. Si P, Zhu C. Biological and neurological activities of astaxanthin. Molecular medicine reports. 2022;26(4):1–12. pmid:35946443
  103. 103. Cheriet T, Ben-Bachir B, Thamri O, Seghiri R, Mancini I. Isolation and biological properties of the natural flavonoids pectolinarin and pectolinarigenin—A review. Antibiotics. 2020;9(7):417. pmid:32708783
  104. 104. Naz I, Saifullah , Khan M. Nematicidal activity of nonacosane-10-ol and 23a-homostigmast-5-en-3β-ol isolated from the roots of Fumaria parviflora (Fumariaceae). Journal of agricultural and food chemistry. 2013;61(24):5689–95. pmid:23713689
  105. 105. Dabur R, Chhillar A, Yadav V, Kamal PK, Gupta J, Sharma G. In vitro antifungal activity of 2-(3, 4-dimethyl-2, 5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative. Journal of medical microbiology. 2005;54(6):549–52. pmid:15888463
  106. 106. Achika J, Ndukwe G, Ayo R. Isolation, characterization and antimicrobial activity of 3β, 22E-stigmasta-5, 22-dien-3-ol from the aerial part of Aeschynomene uniflora E. Mey. British Journal of Pharmaceutical Research. 2016;11(5):1–8.
  107. 107. Khan Z, Nath N, Rauf A, Emran TB, Mitra S, Islam F, et al. Multifunctional roles and pharmacological potential of β-sitosterol: Emerging evidence toward clinical applications. Chemico-biological interactions. 2022;365:110117. pmid:35995256
  108. 108. Gautam V, Kohli SK, Arora S, Bhardwaj R, Kazi M, Ahmad A, et al. Antioxidant and antimutagenic activities of different fractions from the leaves of Rhododendron arboreum Sm. and their GC-MS profiling. Molecules. 2018;23(9):2239. pmid:30177614